News Focus
News Focus
Followers 18
Posts 26514
Boards Moderated 0
Alias Born 09/05/2002

Re: Investorman post# 26

Saturday, 10/19/2002 3:27:00 PM

Saturday, October 19, 2002 3:27:00 PM

Post# of 149
you are right of course but if you had bought cphd anytime it was 3.3 or less for the entire year, you would have made money. they have a solid base and products that work, repeat buyers and a business plan that encourages renewables. with luck they will be profitable next year. they have a very small market cap 100 to 150 million, and if just the strep test is successful with 10% market penetration, which adds 500000 tests a year, they will be profitable. they only have to make 15 to 20 million a year to be profitable and that is about 500 cyclers and 1 million tubes and 500k to 1000K other tests. i think 700 cyclers is easily doable a million tubes is expected since they average over 1000 tubes per cycler now and with more sales they will do more.

with a profit of 5 million and a p to e of 30, that is a solid 5 for the stock without the expectation of more growth. if the air sampler takes hold they can sell it to hospitals.


medicis on the other hand is a risk averse company having been killed on the psoriasis vaccine. they have no killer apps and are dependent on the lack of development in dermatology for their survival

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRX News